Digital Twin Capabilities Expand with New Partnership
Bizzdesign and mpmX have announced a strategic partnership to combine enterprise architecture with process mining, aiming to deliver enhanced 'digital twin of an organization' capabilities. This development aligns with a growing trend in cell and gene therapy manufacturing, where virtual twins are being deployed for in-silico process development and real-time monitoring in GMP environments. The goal is to shorten development timelines and improve data integrity for regulatory compliance.
- Process mining tools, like those from mpmX, create detailed process maps by extracting data from event logs in systems such as MES or LIMS, revealing bottlenecks and deviations from standard operating procedures. This complements enterprise architecture by providing a real-time, data-driven view of how processes are actually performing against the designed blueprint. - In biomanufacturing, digital twins are being developed to model and predict the outcomes of complex processes like cell expansion and bioreactor runs. Companies like Insilico Biotechnology and Ansys are creating simulations to optimize cell culture media and feeding strategies, which has been shown to reduce screening times and scale-up costs. - A significant hurdle in implementing digital twins is integrating data from siloed sources like legacy systems, paper batch records, and disconnected equipment. A successful digital twin requires a robust, integrated data architecture and strong data governance to ensure the data feeding the model is accurate and complete. - For cell and gene therapies, digital twins can simulate supply chain logistics to identify potential bottlenecks and risks associated with factors like variable manufacturing lead times and limited product shelf-life. This allows for probabilistic forecasting to optimize inventory levels and distribution strategies. - Machine learning is being applied to accelerate the engineering of AAV vectors for gene therapies. AI models analyze vast datasets from high-throughput sequencing to identify capsid variants with improved tissue specificity and reduced immunogenicity, a process that is significantly faster than traditional screening methods. - The concept of a "digital product passport" is emerging, where a digital twin documents all process and product data throughout the manufacturing lifecycle. This ensures consistent product quality and helps meet GMP compliance standards like FDA 21 CFR Part 11 for data integrity and electronic records. - Enterprise Architecture (EA) provides the framework for integrating new digital twin technologies with existing systems like ERP, LIMS, and QMS. In biotech, EA helps to create a scalable IT roadmap that aligns technology investments with scientific and business objectives, ensuring that systems are inspection-ready and support, rather than hinder, rapid growth. - While the initial cost of implementing a digital twin—including sensors, software, and data science expertise—is high, the return on investment is calculated based on preventing batch loss, reducing tech transfer times, and improving overall equipment effectiveness (OEE). Some analyses show companies can achieve up to a 30% reduction in operating expenses through predictive maintenance and process optimization.
